G
Gerrit W. Sloof
Researcher at University of Amsterdam
Publications - 33
Citations - 1764
Gerrit W. Sloof is an academic researcher from University of Amsterdam. The author has contributed to research in topics: Neoadjuvant therapy & Esophageal cancer. The author has an hindex of 19, co-authored 33 publications receiving 1681 citations.
Papers
More filters
Journal ArticleDOI
Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer
H. L. van Westreenen,M. Westerterp,Patrick M.M. Bossuyt,Jan Pruim,Gerrit W. Sloof,J. J. B. van Lanschot,Hendricus Groen,J.Th.M. Plukker +7 more
TL;DR: FDG-PET showed moderate sensitivity and specificity for the detection of locoregional metastases, and reasonable sensitivity and Specificity in detection of distant lymphatic and hematogenous metastases.
Journal ArticleDOI
Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters
Marinke Westerterp,Jan Pruim,Wim J.G. Oyen,Otto S. Hoekstra,Anne M. J. Paans,Eric P. Visser,J. Jan B. van Lanschot,Gerrit W. Sloof,Ronald Boellaard +8 more
TL;DR: Standardisation of acquisition, reconstruction and ROI methods is preferred for SUV quantification in multi-centre trials and small unavoidable differences in methodology can be accommodated by performing a phantom study to assess inter-institute correction factors.
Journal ArticleDOI
Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy. Systematic review
Marinke Westerterp,Henderik L van Westreenen,Johannes B. Reitsma,Otto S. Hoekstra,Jaap Stoker,Paul Fockens,Pieter L Jager,Berthe L. F. van Eck-Smit,John T. M. Plukker,J. Jan B. van Lanschot,Gerrit W. Sloof +10 more
TL;DR: CT has poor accuracy for assessment of response to neoadjuvant therapy in patients with esophageal cancer, while Endoscopic US and FDG PET have equivalent good accuracy, but endoscopic US is not always feasible after chemotherapy and radiation therapy.
Journal ArticleDOI
Fluorodeoxyglucose Positron Emission Tomography for Evaluating Early Response During Neoadjuvant Chemoradiotherapy in Patients With Potentially Curable Esophageal Cancer
Mark van Heijl,Jikke M.T. Omloo,Mark I. van Berge Henegouwen,Otto S. Hoekstra,Ronald Boellaard,Patrick M.M. Bossuyt,Olivier R. Busch,Hugo W. Tilanus,Maarten C.C.M. Hulshof,Ate van der Gaast,Grard A. P. Nieuwenhuijzen,Han J. Bonenkamp,J. T. Plukker,Miguel A. Cuesta,Fiebo J.W. ten Kate,Fiebo J.W. ten Kate,Jan Pruim,Herman van Dekken,Jacques J. Bergman,Gerrit W. Sloof,J. Jan B. van Lanschot +20 more
TL;DR: SUV decrease 14 days after the start of chemoradiotherapy was significantly associated with histopathologic tumor response, but its accuracy in detecting nonresponders was too low to justify the clinical use of FDG-PET for early discontinuation of neoadjuvant chemoradaotherapy in patients with potentially curable esophageal cancer.
Journal Article
Synchronous Primary Neoplasms Detected on 18F-FDG PET in Staging of Patients with Esophageal Cancer
Henderik L van Westreenen,Marinke Westerterp,Pieter L. Jager,Hendrik M. van Dullemen,Gerrit W. Sloof,Emile F.I. Comans,J. Jan B. van Lanschot,Theo Wiggers,John T. M. Plukker +8 more
TL;DR: In this paper, the authors determined the rate and clinical relevance of synchronous primary neoplasms seen on F-18-FDG PET in staging of esophageal cancer.